Prolonged-release oxycodone/naloxone reduces opioid-induced constipation and improves quality of life in laxative-refractory patients: results of an observational study.

about

Prolonged-release oxycodone/naloxone reduces opioid-induced constipation and improves quality of life in laxative-refractory patients: results of an observational study.

Item

http://www.wikidata.org/entity/Q48507466

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Prolonged-release oxycodone/na ...... lts of an observational study.

@en

Prolonged-release oxycodone/na ...... lts of an observational study.

@nl

type

Item

label

Prolonged-release oxycodone/na ...... lts of an observational study.

@en

Prolonged-release oxycodone/na ...... lts of an observational study.

@nl

prefLabel

Prolonged-release oxycodone/na ...... lts of an observational study.

@en

Prolonged-release oxycodone/na ...... lts of an observational study.

@nl

P1476

Prolonged-release oxycodone/na ...... lts of an observational study.

@en

P2093

Carsten Bantel

http://www.w3.org/2001/XMLSchema#string

David Molony

http://www.w3.org/2001/XMLSchema#string

Sara Dickerson

http://www.w3.org/2001/XMLSchema#string

Shiva S Tripathi

http://www.w3.org/2001/XMLSchema#string

Susmita Oomman

http://www.w3.org/2001/XMLSchema#string

Tony Heffernan

http://www.w3.org/2001/XMLSchema#string

Vivek Mehta

http://www.w3.org/2001/XMLSchema#string

P2860

Chronic pain epidemiology and its clinical relevance

Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden

Development of opioid-induced constipation: post hoc analysis of data from a 12-week prospective, open-label, blinded-endpoint streamlined study in low-back pain patients treated with prolonged-release WHO step III opioids

Opioid-induced constipation in patients with chronic noncancer pain in the USA, Canada, Germany, and the UK: descriptive analysis of baseline patient-reported outcomes and retrospective chart review

Long-term efficacy and safety of combined prolonged-release oxycodone and naloxone in the management of non-cancer chronic pain.

Incidence, prevalence, and management of opioid bowel dysfunction.

Long-term safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate-to-severe chronic cancer pain.

Opioid-induced bowel dysfunction: pathophysiology and potential new therapies.

Oxycodone and Naloxone Combination: A 12-Week Follow-up in 20 Patients Shows Effective Analgesia Without Opioid-Induced Bowel Dysfunction.

Opiates and elderly: use and side effects.

P304

57-67

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/CEG.S143913

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29416370

http://www.w3.org/2001/XMLSchema#string

P932

5788929

http://www.w3.org/2001/XMLSchema#string